Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes

Alfonso M Durán,1 Lorena M Salto,1 Justin Câmara,1 Anamika Basu,1 Ivette Paquien,1 W Lawrence Beeson,1,2 Anthony Firek,3 Zaida Cordero-MacIntyre,1,2 Marino De León1 1Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, Loma Linda Univers...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Durán AM, Salto LM, Câmara J, Basu A, Paquien I, Beeson WL, Firek A, Cordero-MacIntyre Z, De León M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/d0375f5396ba46fca13736a4d64b3b49
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d0375f5396ba46fca13736a4d64b3b49
record_format dspace
spelling oai:doaj.org-article:d0375f5396ba46fca13736a4d64b3b492021-12-02T04:09:41ZEffects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes1178-7007https://doaj.org/article/d0375f5396ba46fca13736a4d64b3b492019-01-01T00:00:00Zhttps://www.dovepress.com/effects-of-omega-3-polyunsaturated-fatty-acid-supplementation-on-neuro-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Alfonso M Durán,1 Lorena M Salto,1 Justin Câmara,1 Anamika Basu,1 Ivette Paquien,1 W Lawrence Beeson,1,2 Anthony Firek,3 Zaida Cordero-MacIntyre,1,2 Marino De León1 1Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA; 2Center for Nutrition, Healthy Lifestyle and Disease Prevention, School of Public Health, Loma Linda University, Loma Linda, CA, USA; 3Comparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System Medical Center, Moreno Valley, CA, USA Purpose: To determine whether dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduces neuropathic pain symptoms in Mexican-Americans with type 2 diabetes.Methods: Forty volunteers with type 2 diabetes enrolled in the “En Balance-PLUS” program, which provided weekly nutrition–diabetes education and daily supplementation with 1,000 mg docosahexaenoic acid (DHA)–200 mg eicosapentaenoic acid over 3 months. The study assessed self-reported neuropathic pain symptoms pre/postintervention using the short-form McGill Pain Questionnaire (SF-MPQ), monitored clinical laboratory values at baseline and 3 months, and performed baseline and 3-month metabolomic analysis of plasma samples.Results: A total of 26 participants self-reported neuropathic pain symptoms at baseline. After 3 months of omega-3 PUFA supplementation, participants reported significant improvement in SF-MPQ scores (sensory, affective, and visual analogue scale; P<0.001, P=0.012, and P<0.001, respectively). Untargeted metabolomic analysis revealed that participants in the moderate–high SF-MPQ group had the highest relative plasma sphingosine levels at baseline compared to the low SF-MPQ group (P=0.0127) and the nonpain group (P=0.0444). Omega-3 PUFA supplementation increased plasma DHA and reduced plasma sphingosine levels in participants reporting neuropathic pain symptoms (P<0.001 and P<0.001, respectively). Increased plasma DHA levels significantly correlated with improved SF-MPQ sensory scores (r=0.425, P=0.030). Improved SF-MPQ scores, however, did not correlate with clinical/laboratory parameters.Conclusion: The data suggest that omega-3 PUFAs dietary supplementation may reduce neuropathic pain symptoms in individuals with type 2 diabetes and correlates with sphingosine levels in the plasma. Keywords: lipotoxicity, painful diabetic neuropathy, health disparities, community intervention, neuroprotection, LatinosDurán AMSalto LMCâmara JBasu APaquien IBeeson WLFirek ACordero-MacIntyre ZDe León MDove Medical PressarticleLipotoxicityPainful Diabetic NeuropathyNeuropathic PainType 2 DiabetesLatinosOmega-3 polyunsaturated fatty acidsSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 109-120 (2019)
institution DOAJ
collection DOAJ
language EN
topic Lipotoxicity
Painful Diabetic Neuropathy
Neuropathic Pain
Type 2 Diabetes
Latinos
Omega-3 polyunsaturated fatty acids
Specialties of internal medicine
RC581-951
spellingShingle Lipotoxicity
Painful Diabetic Neuropathy
Neuropathic Pain
Type 2 Diabetes
Latinos
Omega-3 polyunsaturated fatty acids
Specialties of internal medicine
RC581-951
Durán AM
Salto LM
Câmara J
Basu A
Paquien I
Beeson WL
Firek A
Cordero-MacIntyre Z
De León M
Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
description Alfonso M Durán,1 Lorena M Salto,1 Justin Câmara,1 Anamika Basu,1 Ivette Paquien,1 W Lawrence Beeson,1,2 Anthony Firek,3 Zaida Cordero-MacIntyre,1,2 Marino De León1 1Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA; 2Center for Nutrition, Healthy Lifestyle and Disease Prevention, School of Public Health, Loma Linda University, Loma Linda, CA, USA; 3Comparative Effectiveness and Clinical Outcomes Research Center, Riverside University Health System Medical Center, Moreno Valley, CA, USA Purpose: To determine whether dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduces neuropathic pain symptoms in Mexican-Americans with type 2 diabetes.Methods: Forty volunteers with type 2 diabetes enrolled in the “En Balance-PLUS” program, which provided weekly nutrition–diabetes education and daily supplementation with 1,000 mg docosahexaenoic acid (DHA)–200 mg eicosapentaenoic acid over 3 months. The study assessed self-reported neuropathic pain symptoms pre/postintervention using the short-form McGill Pain Questionnaire (SF-MPQ), monitored clinical laboratory values at baseline and 3 months, and performed baseline and 3-month metabolomic analysis of plasma samples.Results: A total of 26 participants self-reported neuropathic pain symptoms at baseline. After 3 months of omega-3 PUFA supplementation, participants reported significant improvement in SF-MPQ scores (sensory, affective, and visual analogue scale; P<0.001, P=0.012, and P<0.001, respectively). Untargeted metabolomic analysis revealed that participants in the moderate–high SF-MPQ group had the highest relative plasma sphingosine levels at baseline compared to the low SF-MPQ group (P=0.0127) and the nonpain group (P=0.0444). Omega-3 PUFA supplementation increased plasma DHA and reduced plasma sphingosine levels in participants reporting neuropathic pain symptoms (P<0.001 and P<0.001, respectively). Increased plasma DHA levels significantly correlated with improved SF-MPQ sensory scores (r=0.425, P=0.030). Improved SF-MPQ scores, however, did not correlate with clinical/laboratory parameters.Conclusion: The data suggest that omega-3 PUFAs dietary supplementation may reduce neuropathic pain symptoms in individuals with type 2 diabetes and correlates with sphingosine levels in the plasma. Keywords: lipotoxicity, painful diabetic neuropathy, health disparities, community intervention, neuroprotection, Latinos
format article
author Durán AM
Salto LM
Câmara J
Basu A
Paquien I
Beeson WL
Firek A
Cordero-MacIntyre Z
De León M
author_facet Durán AM
Salto LM
Câmara J
Basu A
Paquien I
Beeson WL
Firek A
Cordero-MacIntyre Z
De León M
author_sort Durán AM
title Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
title_short Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
title_full Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
title_fullStr Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
title_full_unstemmed Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
title_sort effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in mexican-americans with type 2 diabetes
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/d0375f5396ba46fca13736a4d64b3b49
work_keys_str_mv AT duranam effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT saltolm effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT camaraj effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT basua effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT paquieni effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT beesonwl effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT fireka effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT corderomacintyrez effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
AT deleonm effectsofomega3polyunsaturatedfattyacidsupplementationonneuropathicpainsymptomsandsphingosinelevelsinmexicanamericanswithtype2diabetes
_version_ 1718401398521987072